SHSCX Mutual Fund

NAV$48.40

Fund Essentials - as of Feb 27, 2026

Net Assets
$131M
Expense Ratio
1.85%
Dividend Yield (Current)
13.77%
Holdings
165
Inception Date
Oct 16, 2000
Fund Family
BlackRock, Inc. (US)
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD-3.01%
1 Year+15.91%
3 Year+6.73%
5 Year+3.29%
10 Year+8.81%

Asset Allocation

Stocks: 98.52%
Cash: 1.39%
Other: 0.09%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co11.34%
JNJJohnson & Johnson10.22%
ABBVAbbvie Inc4.11%
GILDGilead Sciences Inc3.96%
MRKMerck & Company Inc3.55%
Top 10 Concentration: 46.91%Report Date: Feb 27, 2026
Download all 165 holdings for SHSCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
13.77%
Frequency
Annually
Latest Distribution
$4.01
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

SHSCX Mutual Fund Overview

SHSCX Mutual Fund (BlackRock Health Sciences Opportunity Fund Investor C Class) is managed by BlackRock, Inc. (US) with $130.9M in net assets. SHSCX expense ratio is 1.85%, holding 165 positions across sectors including Health Care, Unknown, Financials. Inception date: 2000-10-16.

SHSCX performance shows a YTD return of -3.01%. The 1-year return is 15.91% and the 5-year return is 3.29%. SHSCX dividend yield stands at 13.77%, paid annually.

SHSCX top holdings include Eli Lilly & Co (11.3%), Johnson & Johnson (10.2%), Abbvie Inc (4.1%), Gilead Sciences Inc (4.0%), Merck & Company Inc (3.5%). View all SHSCX holdings, sector breakdown, or dividend history.

SHSCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. SHSCX alternatives are available via the screener, along with tax-loss harvesting opportunities.